Cargando…

How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework

OBJECTIVES: To review the pragmatism of published randomized trials of remdesivir and favipiravir based on the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS-2) framework. STUDY DESIGN AND SETTING: Ten eligible trials were identified from an existing comprehensive living review and were e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Tanmay, Qamar, Intisar, Zwarenstein, Merrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Covid-19 Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576695/ https://www.ncbi.nlm.nih.gov/pubmed/36265553 http://dx.doi.org/10.1016/j.jclinepi.2022.10.013

Ejemplares similares

The relationship between pragmatism, timing, and study size on impact of randomized trials: a qualitative, hypothesis generating study of trials of systemic corticosteroids for COVID-19
por: Liang, Aileen, et al.
Publicado: (2022)

Tocilizumab, Remdesivir, Favipiravir, and Dexamethasone Repurposed for COVID-19: a Comprehensive Clinical and Pharmacovigilant Reassessment
por: Kelleni, Mina T.
Publicado: (2021)

Methodology and design of platform trials: a meta-epidemiological study
por: Pitre, Tyler, et al.
Publicado: (2023)

Acute Psychosis in COVID-19: Is It Due to Favipiravir Treatment or Acute Viral Illness?
por: Duyan, Murat, et al.
Publicado: (2021)

Inpatient remdesivir versus nirmatrelvir-ritonavir in the progression of COVID-19
por: Patel, Dimple, et al.
Publicado: (2023)

PRECIS-2: a tool to improve the applicability of randomised controlled trials
por: Loudon, Kirsty, et al.
Publicado: (2013)

Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective
por: Gandhi, Zainab, et al.
Publicado: (2020)

Noninterventional studies in the COVID-19 era: methodological considerations for study design and analysis
por: Butler, Anne M., et al.
Publicado: (2023)

Understanding how deferred consent affects patient characteristics and outcomes: an exploratory analysis of a clinical trial of prone positioning for COVID-19
por: Colacci, Michael, et al.
Publicado: (2023)

Artificial intelligence in COVID-19 evidence syntheses was underutilized, but impactful: a methodological study
por: Tercero-Hidalgo, Juan R., et al.
Publicado: (2022)

Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis
por: Tao, Jun, et al.
Publicado: (2021)

Stewardship of Remdesivir Use in a Rural Community Hospital During the COVID-19 Pandemic
por: Tirupathi, Raghavendra, et al.
Publicado: (2021)

Protocol refinement for a diabetes pragmatic trial using the PRECIS-2 framework
por: Glasgow, Russell E., et al.
Publicado: (2021)

High-cited favorable studies for COVID-19 treatments ineffective in large trials
por: Ioannidis, John P.A.
Publicado: (2022)

Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose
por: Loudon, Kirsty, et al.
Publicado: (2013)

A framework for identifying and mitigating the equity harms of COVID-19 policy interventions
por: Glover, Rebecca E., et al.
Publicado: (2020)

Toward an observatory of the evolution of clinical trials through phylomemy reconstruction: the COVID-19 vaccines example
por: Lobbé, Quentin, et al.
Publicado: (2022)

Making trials matter: pragmatic and explanatory trials and the problem of applicability
por: Treweek, Shaun, et al.
Publicado: (2009)

Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool
por: Norton, Wynne E., et al.
Publicado: (2021)

Integrating travel history via big data analytics under universal healthcare framework for disease control and prevention in the COVID-19 pandemic
por: Ma, Kevin Sheng-Kai
Publicado: (2021)

LGBTQ+ Inclusive Palliative Care in the Context of COVID-19: Pragmatic Recommendations for Clinicians
por: Rosa, William E., et al.
Publicado: (2020)

Matching trial design decisions to the needs of those you hope will use the results: the PRECIS-2 tool
por: Loudon, Kirsty, et al.
Publicado: (2015)

Management of Acute Coronary Syndromes During the Coronavirus Disease 2019 Pandemic: Deviations from Guidelines and Pragmatic Considerations for Patients and Healthcare Workers
por: Seligman, Henry, et al.
Publicado: (2020)

Description of Covid-19 Cases in Brazil and Italy
por: de Souza Ferreira, Luiz Philipe, et al.
Publicado: (2020)

Prone Positioning for Severe Acute Respiratory Distress Syndrome in COVID-19 Patients by a Dedicated Team: A Safe and Pragmatic Reallocation of Medical and Surgical Work Force in Response to the Outbreak
por: Doussot, Alexandre, et al.
Publicado: (2020)

Systematic and Statistical Review of Coronavirus Disease 19 Treatment Trials
por: Siordia, Juan A., et al.
Publicado: (2020)

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
por: Tao, Sijia, et al.
Publicado: (2021)

The first community outbreak of COVID-19 in Viet Nam: description and lessons learned
por: Duong, Tran Nhu, et al.
Publicado: (2019)

COVID‐19 in one region of New Zealand: a descriptive epidemiological study
por: Hammond, Vanessa, et al.
Publicado: (2022)

European Society of Cardiology Highlights: Late-breaking Trials – COVID-19
por: Komiyama, Maki, et al.
Publicado: (2022)

Exclusion of Reproductive-aged Women in COVID-19 Vaccination and Clinical Trials
por: Kons, Kelly M., et al.
Publicado: (2022)

SG-APSIC1113: Descriptive study on COVID-19 exposures in Singapore General Hospital
por: Shawn See, Wee Jin
Publicado: (2023)

Elective Surgery and COVID-19: A Framework for the Untested Patient
por: Lu, Amy C., et al.
Publicado: (2020)

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19
por: Whittington, Melanie D., et al.
Publicado: (2022)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
por: Spitzer, Ernest, et al.
Publicado: (2020)

Descriptive epidemiology of the first wave of COVID-19 in Petaling District, Malaysia: Focus on asymptomatic transmission
por: Supramanian, Rama Krishna, et al.
Publicado: (2021)

Descriptive analysis of deaths associated with COVID-19 in Fiji, 15 April to 14 November 2021
por: Sharma, Nashika, et al.
Publicado: (2022)

Heterogeneity in pragmatic randomised trials: sources and management
por: Giraudeau, Bruno, et al.
Publicado: (2022)

Protective Effects of CVD and DM Medications in SARS-CoV-2 Infection
por: Bangi, Shifa, et al.
Publicado: (2020)

Lung Ultrasound and Respiratory Pathophysiology in Mechanically Ventilated COVID-19 Patients—an Observational Trial
por: Rojatti, Marco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fv2v2bpr1jlud29b8ptggue8jr